Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis.
The residues of anti-neoplastic drugs are new and emerging pollutants in aquatic environments. This is not only because of their increasing use, but also because due to their mechanisms of action, they belong to a group of particularly dangerous compounds. However, information on their ecotoxicological properties is very limited. We tested the toxicities of four anti-neoplastic drugs with different mechanisms of action (5-fluorouracil [5-FU], cisplatin [CDDP], etoposide [ET], and imatinib mesylate [IM]), and some of their binary mixtures, against two phytoplankton species: the alga Pseudokirchneriella subcapitata, and the cyanobacterium Synechococcus leopoliensis. These four drugs showed different toxic potential, and the two species examined also showed differences in their susceptibilities towards the tested drugs and their mixtures. With P. subcapitata, the most toxic of these drugs was 5-FU (EC50, 0.13 mg/L), followed by CDDP (EC50, 1.52 mg/L), IM (EC50, 2.29 mg/L), and the least toxic, ET (EC50, 30.43 mg/L). With S. leopoliensis, the most toxic was CDDP (EC50, 0.67 mg/L), followed by 5-FU (EC50, 1.20 mg/L) and IM (EC50, 5.36 mg/L), while ET was not toxic up to 351 mg/L. The toxicities of the binary mixtures tested (5-FU + CDDP, 5-FU + IM, CDDP + ET) were predicted by the concepts of 'concentration addition' and 'independent action', and are compared to the experimentally determined toxicities. The measured toxicity of 5-FU + CDDP with P. subcapitata and S. leopoliensis was higher than that predicted, while the measured toxicity of CDDP + ET with both species was lower than that predicted. The measured toxicity of 5-FU + IM with P. subcapitata was higher, and with S. leopoliensis was lower, than that predicted. These data show that these mixtures can have compound-specific and species-specific synergistic or antagonistic effects, and they suggest that single compound toxicity data are not sufficient for the prediction of the aquatic toxicities of such anticancer drug mixtures.
Ecological Engineering Institute, Ljubljanska 9, 2000 Maribor, Slovenia.
Polona
P
Brezovšek
Department for Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000 Ljubljana, Slovenia.
Tina
T
Eleršek
Department for Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna pot 111, 1000 Ljubljana, Slovenia. Electronic address: metka.filipic@nib.si.
Metka
M
Filipič
D000970:Antineoplastic Agents / Q000633:toxicity*; D001549:Benzamides / Q000633:toxicity; D000460:Chlorophyta / Q000187:drug effects*; D002945:Cisplatin / Q000633:toxicity; D045424:Complex Mixtures / Q000633:toxicity; D004357:Drug Synergism; D054750:Ecotoxicology / Q000379:methods; D005047:Etoposide / Q000633:toxicity; D005472:Fluorouracil / Q000633:toxicity; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000633:toxicity; D011743:Pyrimidines / Q000633:toxicity; D046940:Synechococcus / Q000187:drug effects*; D014874:Water Pollutants, Chemical / Q000633:toxicity*
D000970:Antineoplastic Agents; D001549:Benzamides; D045424:Complex Mixtures; D010879:Piperazines; D011743:Pyrimidines; D014874:Water Pollutants, Chemical; D005047:Etoposide; D000068877:Imatinib Mesylate; D002945:Cisplatin; D005472:Fluorouracil
Anti-neoplastic drugs; Aquatic toxicity; Cyanobacteria; Drug toxicity; Green algae; Mixture toxicity; Pharmaceuticals in the aquatic environment